These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 35089354)

  • 1. Association of Antihypertensives That Stimulate vs Inhibit Types 2 and 4 Angiotensin II Receptors With Cognitive Impairment.
    Marcum ZA; Cohen JB; Zhang C; Derington CG; Greene TH; Ghazi L; Herrick JS; King JB; Cheung AK; Bryan N; Supiano MA; Sonnen JA; Weintraub WS; Williamson J; Pajewski NM; Bress AP;
    JAMA Netw Open; 2022 Jan; 5(1):e2145319. PubMed ID: 35089354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk of Mild Cognitive Impairment or Probable Dementia in New Users of Angiotensin II Receptor Blockers and Angiotensin-Converting Enzyme Inhibitors: A Secondary Analysis of Data From the Systolic Blood Pressure Intervention Trial (SPRINT).
    Cohen JB; Marcum ZA; Zhang C; Derington CG; Greene TH; Ghazi L; Herrick JS; King JB; Cheung AK; Bryan N; Supiano MA; Sonnen JA; Weintraub WS; Scharfstein D; Williamson J; Pajewski NM; Bress AP;
    JAMA Netw Open; 2022 Jul; 5(7):e2220680. PubMed ID: 35834254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of New Use of Antihypertensives That Stimulate vs Inhibit Type 2 and 4 Angiotensin II Receptors With Dementia Among Medicare Beneficiaries.
    Marcum ZA; Gabriel N; Bress AP; Hernandez I
    JAMA Netw Open; 2023 Jan; 6(1):e2249370. PubMed ID: 36598787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of Antihypertensives and Cognitive Impairment in Long-Term Care Residents.
    Marcum ZA; Li Y; Lee SJ; Steinman MA; Graham L; Jing B; Fung K; Peralta CA; Odden MC
    J Alzheimers Dis; 2022; 86(3):1149-1158. PubMed ID: 35147539
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identifying Patients for Intensive Blood Pressure Treatment Based on Cognitive Benefit: A Secondary Analysis of the SPRINT Randomized Clinical Trial.
    Ghazi L; Shen J; Ying J; Derington CG; Cohen JB; Marcum ZA; Herrick JS; King JB; Cheung AK; Williamson JD; Pajewski NM; Bryan N; Supiano M; Sonnen J; Weintraub WS; Greene TH; Bress AP
    JAMA Netw Open; 2023 May; 6(5):e2314443. PubMed ID: 37204788
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of Intensive vs Standard Blood Pressure Control on Probable Dementia: A Randomized Clinical Trial.
    ; Williamson JD; Pajewski NM; Auchus AP; Bryan RN; Chelune G; Cheung AK; Cleveland ML; Coker LH; Crowe MG; Cushman WC; Cutler JA; Davatzikos C; Desiderio L; Erus G; Fine LJ; Gaussoin SA; Harris D; Hsieh MK; Johnson KC; Kimmel PL; Tamura MK; Launer LJ; Lerner AJ; Lewis CE; Martindale-Adams J; Moy CS; Nasrallah IM; Nichols LO; Oparil S; Ogrocki PK; Rahman M; Rapp SR; Reboussin DM; Rocco MV; Sachs BC; Sink KM; Still CH; Supiano MA; Snyder JK; Wadley VG; Walker J; Weiner DE; Whelton PK; Wilson VM; Woolard N; Wright JT; Wright CB
    JAMA; 2019 Feb; 321(6):553-561. PubMed ID: 30688979
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of Angiotensin II-Stimulating Antihypertensive Use and Dementia Risk: Post Hoc Analysis of the PreDIVA Trial.
    van Dalen JW; Marcum ZA; Gray SL; Barthold D; Moll van Charante EP; van Gool WA; Crane PK; Larson EB; Richard E
    Neurology; 2021 Jan; 96(1):e67-e80. PubMed ID: 33154085
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of Blood Pressure Lowering With Incident Dementia or Cognitive Impairment: A Systematic Review and Meta-analysis.
    Hughes D; Judge C; Murphy R; Loughlin E; Costello M; Whiteley W; Bosch J; O'Donnell MJ; Canavan M
    JAMA; 2020 May; 323(19):1934-1944. PubMed ID: 32427305
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of Therapeutic Inertia and Race and Ethnicity in the Systolic Blood Pressure Intervention Trial: A Secondary Analysis of a Randomized Clinical Trial.
    Zheutlin AR; Mondesir FL; Derington CG; King JB; Zhang C; Cohen JB; Berlowitz DR; Anstey DE; Cushman WC; Greene TH; Ogedegbe O; Bress AP
    JAMA Netw Open; 2022 Jan; 5(1):e2143001. PubMed ID: 35006243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antihypertensive Medication Class and the Risk of Dementia and Cognitive Decline in Older Adults: A Secondary Analysis of the Prospective HELIAD Cohort.
    Liampas I; Hatzimanolis A; Siokas V; Yannakoulia M; Kosmidis MH; Sakka P; Hadjigeorgiou GM; Scarmeas N; Dardiotis E
    J Alzheimers Dis; 2022; 89(2):709-719. PubMed ID: 35912747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of intensive blood pressure control on subtypes of mild cognitive impairment and risk of progression from SPRINT study.
    Gaussoin SA; Pajewski NM; Chelune G; Cleveland ML; Crowe MG; Launer LJ; Lerner AJ; Martindale-Adams J; Nichols LO; Ogrocki PK; Sachs BC; Sink KM; Supiano MA; Wadley VG; Wilson VM; Wright CB; Williamson JD; Reboussin DM; Rapp SR
    J Am Geriatr Soc; 2022 May; 70(5):1384-1393. PubMed ID: 34826341
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Depressive symptoms, antidepressant use, and future cognitive health in postmenopausal women: the Women's Health Initiative Memory Study.
    Goveas JS; Hogan PE; Kotchen JM; Smoller JW; Denburg NL; Manson JE; Tummala A; Mysiw WJ; Ockene JK; Woods NF; Espeland MA; Wassertheil-Smoller S
    Int Psychogeriatr; 2012 Aug; 24(8):1252-64. PubMed ID: 22301077
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of intensive versus standard blood pressure control on domain-specific cognitive function: a substudy of the SPRINT randomised controlled trial.
    Rapp SR; Gaussoin SA; Sachs BC; Chelune G; Supiano MA; Lerner AJ; Wadley VG; Wilson VM; Fine LJ; Whittle JC; Auchus AP; Beddhu S; Berlowitz DR; Bress AP; Johnson KC; Krousel-Wood M; Martindale-Adams J; Miller EC; Rifkin DE; Snyder JK; Tamariz L; Wolfgram DF; Cleveland ML; Yang M; Nichols LO; Bryan RN; Reboussin DM; Williamson JD; Pajewski NM;
    Lancet Neurol; 2020 Nov; 19(11):899-907. PubMed ID: 33098800
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence and Outcomes of Amyloid Positivity Among Persons Without Dementia in a Longitudinal, Population-Based Setting.
    Roberts RO; Aakre JA; Kremers WK; Vassilaki M; Knopman DS; Mielke MM; Alhurani R; Geda YE; Machulda MM; Coloma P; Schauble B; Lowe VJ; Jack CR; Petersen RC
    JAMA Neurol; 2018 Aug; 75(8):970-979. PubMed ID: 29710225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The effect of angiotensin receptor blockers in cerebrovascular disorders and dementia: bonus in addition to the antihypertensive effect].
    Kovács T
    Ideggyogy Sz; 2014 May; 67(5-6):149-68. PubMed ID: 25087375
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kidney Disease, Intensive Hypertension Treatment, and Risk for Dementia and Mild Cognitive Impairment: The Systolic Blood Pressure Intervention Trial.
    Kurella Tamura M; Gaussoin SA; Pajewski NM; Chelune GJ; Freedman BI; Gure TR; Haley WE; Killeen AA; Oparil S; Rapp SR; Rifkin DE; Supiano M; Williamson JD; Weiner DE;
    J Am Soc Nephrol; 2020 Sep; 31(9):2122-2132. PubMed ID: 32591439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conjugated equine estrogens and incidence of probable dementia and mild cognitive impairment in postmenopausal women: Women's Health Initiative Memory Study.
    Shumaker SA; Legault C; Kuller L; Rapp SR; Thal L; Lane DS; Fillit H; Stefanick ML; Hendrix SL; Lewis CE; Masaki K; Coker LH;
    JAMA; 2004 Jun; 291(24):2947-58. PubMed ID: 15213206
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estimating the Prevalence of Dementia and Mild Cognitive Impairment in the US: The 2016 Health and Retirement Study Harmonized Cognitive Assessment Protocol Project.
    Manly JJ; Jones RN; Langa KM; Ryan LH; Levine DA; McCammon R; Heeringa SG; Weir D
    JAMA Neurol; 2022 Dec; 79(12):1242-1249. PubMed ID: 36279130
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Malignant left ventricular hypertrophy and risk of cognitive impairment in SPRINT MIND trial.
    Kazibwe R; Ahmad MI; Hughes TM; Chen LY; Soliman EZ
    Am Heart J; 2024 Oct; 276():31-38. PubMed ID: 39067559
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of Brain Magnetic Resonance Imaging Signs With Cognitive Outcomes in Persons With Nonimpaired Cognition and Mild Cognitive Impairment.
    Wu A; Sharrett AR; Gottesman RF; Power MC; Mosley TH; Jack CR; Knopman DS; Windham BG; Gross AL; Coresh J
    JAMA Netw Open; 2019 May; 2(5):e193359. PubMed ID: 31074810
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.